Search results

This quality standard covers diagnostic reporting and the organisation of haematological cancer services for people of all ages (children, adults and young people) and managing haematological cancers in adults and young people (aged 16 and over). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

1 June 2017

Evidence-based recommendations on circular stapled haemorrhoidectomy. This involves cutting out a circular strip of the lining of the rectum (the rectal mucosa) above the haemorrhoids to reduce the blood supply to the haemorrhoids, so that they shrink.

Result type

Interventional procedures guidance

Published

17 December 2003

This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating care.

Result type

NICE guideline

Published

3 October 2018

Evidence-based recommendations on ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years and over.

Result type

Technology appraisal guidance

Published

27 March 2024

Evidence-based recommendations on apremilast (Otezla) for treating active psoriatic arthritis.

Result type

Technology appraisal guidance

Published

22 February 2017

Evidence-based recommendations on EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing.

Result type

HealthTech guidance

Last updated

8 October 2019

Evidence-based recommendations on abiraterone (Zytiga) for castration-resistant metastatic prostate cancer in adults who have had previous treatment with a docetaxel-containing regimen.

Result type

Technology appraisal guidance

Last updated

27 July 2016

Evidence-based recommendations on regorafenib (Stivarga) for treating advanced hepatocellular carcinoma in adults who have had sorafenib.

Result type

Technology appraisal guidance

Published

9 January 2019

Evidence-based recommendations on omalizumab (Xolair) for treating severe persistent allergic asthma in people aged 6 and over.

Result type

Technology appraisal guidance

Published

24 April 2013

Evidence-based recommendations on lorlatinib (Lorviqua) for previously treated ALK-positive advanced non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

13 May 2020

Evidence-based recommendations on entecavir for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

27 August 2008

Evidence-based recommendations on infliximab for treating moderate to severe psoriasis in adults.

Result type

Technology appraisal guidance

Published

23 January 2008

Evidence-based recommendations on dabrafenib (Tafinlar) for treating unresectable or metastatic melanoma in adults with a BRAF V600 mutation.

Result type

Technology appraisal guidance

Published

22 October 2014

Evidence-based recommendations on coil embolisation of ruptured intracranial aneurysms. This involves passing a thin tube through the body to place coils inside the aneurysm.

Result type

Interventional procedures guidance

Published

26 January 2005

Evidence-based recommendations on the Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms.

Result type

HealthTech guidance

Last updated

9 January 2019